Inhibitor Therapeutics's total assets for Q1 2026 were $1.43M, a decrease of -42.92% from the previous quarter. INTI total liabilities were $3.41M for the fiscal quarter, a -10.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.